<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03847597</url>
  </required_header>
  <id_info>
    <org_study_id>7168</org_study_id>
    <nct_id>NCT03847597</nct_id>
  </id_info>
  <brief_title>Histological and Imaging Assessment of the Structural Characteristics of the Femoro-popliteal Arterial Segment</brief_title>
  <official_title>Histological and Imaging Assessment of the Structural Characteristics of the Femoro-popliteal Arterial Segment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The femoro-popliteal arterial segment is one of the most frequent locations for
      atherosclerosis. Its management is mainly endovascular (standard and coated-balloon
      angioplasty, stenting).

      However, the structural features of the atherosclerotic disease in regards to patient's risk
      factors and past medical and surgical histories are not well studied. Furthermore, the
      histological analysis of the femoro-popliteal arterial segment is rare in the literature, and
      made difficult mostly because of the length of this segment.

      There is a clinical need for better understanding of atherosclerotic lesions in this
      location, with as further goal, a better management of this disease.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 2019</start_date>
  <completion_date type="Anticipated">February 2022</completion_date>
  <primary_completion_date type="Anticipated">April 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Descriptive analysis of the arterial structure in micro-CT.</measure>
    <time_frame>3 years</time_frame>
    <description>study precisely the pathological structure of the femoro-popliteal arterial segment in AOMI, both in imaging and histologically.</description>
  </primary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Chronic Limb Ischemia</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Explantation of the femoro-popliteal arterial segment from the amputed limb</intervention_name>
    <description>Explantation of the femoro-popliteal arterial segment from the amputed limb</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with chronic limb ischemia that are scheduled for transfemoral amputation
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Age &gt; 18 years old

          -  Men and women

          -  Patient with chronic limb ischemia that is scheduled for transfemoral amputation in
             the University Hospital of Strasbourg

          -  Patient giving his -non-opposition to the explantation and use of the femoro-popliteal
             arterial segment

        Exclusion criteria:

          -  Refusal to give his consent

          -  Impossibility to give clear information to the patient

          -  Pregnant and breastfeeding women

          -  Patient under administrative protection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nabil CHAKFE</last_name>
    <role>Principal Investigator</role>
    <affiliation>Les Hôpitaux Universitaires de Strasbourg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nabil CHAKFE</last_name>
    <phone>+33 3 69 55 08 88</phone>
    <email>nabil.chakfe@chru-strasbourg.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Les Hôpitaux Universitaires de Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Nabil CHAKFE</last_name>
      <phone>+ 33 3 69 55 08 88</phone>
      <email>nabil.chakfe@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Fabien THAVEAU</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anne LEJAY</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yannick GEORG</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2018</verification_date>
  <study_first_submitted>December 18, 2018</study_first_submitted>
  <study_first_submitted_qc>February 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 20, 2019</study_first_posted>
  <last_update_submitted>March 25, 2019</last_update_submitted>
  <last_update_submitted_qc>March 25, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 26, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

